Effectiveness of a Physiotherapy Treatment for Temporomandibular Hyperlaxity
Sponsor
Universidad Católica de Ávila (Other)
Overall Status
Completed
CT.gov ID
NCT04811495
Collaborator
(none)
1
1
1
1.4
0.7
Study Details
Study Description
Brief Summary
A 14-day physiotherapy treatment for temporomandibular joint hyperlaxity is established. Pre-intervention measurements and intermediate and end-of-treatment measurements are taken. Range of movement, algometry and muscle balance are assessed.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Actual Enrollment
:
1 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effectiveness of a Physiotherapy Treatment for Temporomandibular Hyperlaxity: a Case Report.
Actual Study Start Date
:
Feb 5, 2021
Actual Primary Completion Date
:
Mar 1, 2021
Actual Study Completion Date
:
Mar 19, 2021
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: patient with temporomandibular joint disorders
|
Other: Physiotherapy treatment
A treatment plan is carried out which aims to improve pain, muscle balance and range of motion of the temporomandibular joint.
|
Outcome Measures
Primary Outcome Measures
- Range motion [14 days]
The range of movement in the temporomandibular joint is assessed.
- VAS [14 days]
Pain in the temporomandibular artiuclation measured with an algometer and VAS is assessed.
- Strength [14 days]
The strength of the temporomandibular joint musculature measured with an algometer is assessed.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Woman with temporomandicular joint pain for six months and diagnosed with hyperlaxity in the joint.
Exclusion Criteria:
-
Men
-
No temporomandibular joint pain or hyperlaxity
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Universidad Católica de Ávila | Ávila | Spain | 05005 |
Sponsors and Collaborators
- Universidad Católica de Ávila
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
JORGE VELAZQUEZ SAORNIL,
Clinical Professor,
Universidad Católica de Ávila
ClinicalTrials.gov Identifier:
NCT04811495
Other Study ID Numbers:
- 19/03/2021
First Posted:
Mar 23, 2021
Last Update Posted:
Mar 23, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by JORGE VELAZQUEZ SAORNIL,
Clinical Professor,
Universidad Católica de Ávila
Additional relevant MeSH terms: